Tumor targeting properties of antibody fusion proteins based on different members of the murine tumor necrosis superfamily

Authors:

Abstract
No abstract available
Funding Information
  • ETH Zurich
  • Swiss National Science Foundation
  • Kommission für Technologie und Innovation (KTI Medtech Award)
  • European Union (FP7 Project PRIAT)
  • Philochem AG

This publication has 29 references indexed in Scilit: